Email RIS file
Bookmark
Report an Issue

Guidance for industry : CGMP for phase 1 investigational drugs

Additional Titles
CGMP for phase 1 investigational drugs
Published
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research : Office of Regulatory Affairs, [2008]
Physical Description
17 pages : digital, PDF file
Additional Creators
Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.), and United States. Food and Drug Administration. Office of Regulatory Affairs
Access Online

Availability

I Want It
I Want It

Finding items...

Restrictions on Access
Free-to-read Unrestricted online access
Report Numbers
HE 20.4802:IN 8
Subject(s)
Note
Title from PDF title page (viewed on Apr. 21, 2009).
"July 2008."
Bibliography Note
Includes bibliographical references (page 17).
Technical Details
Mode of access: Internet at the FDA CBER Web site. Address as of 4/21/09: http://www.fda.gov/cber/gdlns/indcgmp.pdf ; current access is available via PURL.
Action Note
committed to retain. Federal Depository Library Program (FDLP). For information on our retention commitment, please contact Microforms and Government Information.
View MARC record | catkey: 5303389